The genotypic and phenotypic data were collected from 60 tobacco leaf samples of three cultivars, from four development stages and three positions in the plants and grown in two cultivation environments. The potential application of the QTX results in breeding practice was also discussed. In 2010, three tobacco cultivars (K326, Hongda and Zunyan 6) were grown in farm fields at Guiding (26.58° N, 107.23°

E) and Xingyi (25.08° N, 104.90° E) under normal condition for crop production in Guizhou province, China. The plants of three cultivars were planted in 10 rows with 30 plants per row and in three blocks. The plant-to-plant spaces between and within rows were 100 cm and 50 cm, respectively. For each of PTC124 ic50 the three cultivars, leaves of 25 plants from 5 points were pooled for 1) the combination of upper or middle leaves from two locations within the plant at four developmental time points with sampling

every 12 days, and 2) the lower leaves from two locations within the plant at two developmental time points, thus resulting in a total of 60 samples. The pooled leaves were immediately frozen in liquid nitrogen and stored at − 80 °C for further use. A methylation DArT chip for tobacco was developed by Diversity Array Technology Ltd. (Canberra, Australia) as PARP inhibition described at http://www.diversityarrays.com/dnamethylation.html. Total DNA was extracted and hybridization followed the DArT methylation profiling protocol as described by Lu et al. [23]. The program

Montelukast Sodium DArT Soft was used to determine whether the fragments in the arrays tested for each sample were methylated or not. A custom-designed microarray platform was used for the analysis of total RNA extracted from the tobacco leaf samples. The microarray was comprised of three 60-mer probes for each of 44,873 unigenes derived from public Expressed Sequence Tags (ESTs) of tobacco and was made following a protocol provided by Roche Co. (http://www.nimblegen.com/). The 60-mer probes were chosen from a group of six to seven non-overlapping probes designed against different parts of each gene model. The probes with E-values most similar to the average of the six to seven non-overlapping experimental probes were assumed to be the most reliable for transcript level estimation. Total RNA was extracted with the RNeasy Mini Kit (Qiagen Corp, Valencia, CA, United States) and DNase treated in-column with the RNase-Free DNase set (also from Qiagen). Double-stranded cDNA was synthesized using the SuperScript Double Strand cDNA Synthesis Kit (Invitrogen Inc., Carlsbad, CA, United States) with oligo (dT) primers following the manufacturer’s protocol. Cy-3 and Cy-5 labeling and hybridization steps were performed by NimbleGen using standard procedures (http://www.nimblegen.com/). Expression values were generated by Roche NimbleGen proprietary software using quantile normalization [24] and the Robust Multichip Average algorithm [25].